NYKD · Nykode Therapeutics ASA

4.56

NOK

0.05 (1.11%)

24/08/2026 12:00:00 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

NOK1.47B

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 24/08/2026 12:00:00 AM

Price Chart

Description

Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. It focuses on developing field of individualized cancer neoantigen vaccines by using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on November 22, 2006 and is headquartered in Oslo, Norway.

All-Companies
All-Consensus
Big Candle
HALO 200
HALO All
HALO Consensus Value
HALO Earnings Momentum
HALO Momentum
HALO Price Momentum
HALO Small
Hammer Bearish (Realtime)
Short Term Trend - Long
Volume Spike

Key Fundamentals

EPS 3 yr Growth

-74.60%

EBITDA Margin

N/A

Operating Cashflow

-$26m

Free Cash Flow Return

-21.50%

ROIC

-10.10%

Interest Coverage

-214.50

Quick Ratio

10.00

Performance

52 weeks range

Low 1.44 - 5.17

Trade Value (12mth)

US$78,027.00

1 week

33.23%

1 month

41.38%

YTD

91.43%

1 year

157.42%

All time high

93.00

Additional Data

Shares Outstanding (Fully Diluted)

327m

HALO Sector

Healthcare

Next Company Report Date

24-Feb-27

Next Ex Dividend Date

27-May-25

Next Dividend Pay Date

12-Jun-25

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Very Strong

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

No announcements available.

Key Stakeholders

Name	Title
Jan Haudemann-Andersen	Individual
Rasmussen Family	Individual
Andenaes Family	Individual
NORDA ASA	Public Company
Joh Johannson Eiendom AS	Private Company